Rare and inherited diseases affect millions of patients worldwide, many of whom wait years for a diagnosis. Germline genomic testing, from targeted panels to exomes and genomes, has become central to shortening that diagnostic journey, provided labs can efficiently prioritize the variants that explain each patient's phenotype.
In this section, you will find our articles on rare and inherited disease genomics: germline variant interpretation, phenotype-driven prioritization, CNV detection, case studies from diagnostic labs, and updates on how SeqOne helps teams reach more diagnoses, faster.
DiagAI uses inheritance & quality rules based on real diagnostic data, enabling clinicians to understand AI recommendations and collaborate on system improvement.